Cite
Comparative Genomic Hybridization, Gene Expression Profiling and Whole Genome Sequencing Analysis of Disease Progression in Myeloma Reveals Vigorous Clonal Evolution in Patients with High Baseline Genetic Risk
MLA
P. Leif Bergsagel, et al. “Comparative Genomic Hybridization, Gene Expression Profiling and Whole Genome Sequencing Analysis of Disease Progression in Myeloma Reveals Vigorous Clonal Evolution in Patients with High Baseline Genetic Risk.” Blood, vol. 114, Nov. 2009, p. 2810. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........10e9e4fa0343b64612acdb3c8f25716a&authtype=sso&custid=ns315887.
APA
P. Leif Bergsagel, Rodger E. Tiedemann, A. Keith Stewart, John D. Carpten, Jonathan J Keats, & Jan B. Egan. (2009). Comparative Genomic Hybridization, Gene Expression Profiling and Whole Genome Sequencing Analysis of Disease Progression in Myeloma Reveals Vigorous Clonal Evolution in Patients with High Baseline Genetic Risk. Blood, 114, 2810.
Chicago
P. Leif Bergsagel, Rodger E. Tiedemann, A. Keith Stewart, John D. Carpten, Jonathan J Keats, and Jan B. Egan. 2009. “Comparative Genomic Hybridization, Gene Expression Profiling and Whole Genome Sequencing Analysis of Disease Progression in Myeloma Reveals Vigorous Clonal Evolution in Patients with High Baseline Genetic Risk.” Blood 114 (November): 2810. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........10e9e4fa0343b64612acdb3c8f25716a&authtype=sso&custid=ns315887.